Tonix Pharmaceuticals Holding Corp. (TNXP) Press Releases https://ir.tonixpharma.com/news-events/press-releases/rss en-us https://s3.amazonaws.com/equisolve-dev4/tonixpharma/files/theme/images/logo-sm.png Tonix Pharmaceuticals Holding Corp. Logo Equisolve Investor Relations Suite <![CDATA[Tonix Pharmaceuticals Announces Positive Minutes from Type C FDA Meeting to Discuss Adaptive Phase 2 Field Study of TNX-4800, a Human, anti-OspA Monoclonal Antibody, to Prevent Lyme Disease in the U.S.]]> https://ir.tonixpharma.com/news-events/press-releases/detail/1638/tonix-pharmaceuticals-announces-positive-minutes-from-type Mon, 03 Aug 26 07:00:00 -0400 https://ir.tonixpharma.com/news-events/press-releases/detail/1638/tonix-pharmaceuticals-announces-positive-minutes-from-type <![CDATA[Tonix Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 10, 2026]]> https://ir.tonixpharma.com/news-events/press-releases/detail/1637/tonix-pharmaceuticals-to-report-second-quarter-2026 Mon, 27 Jul 26 07:00:00 -0400 https://ir.tonixpharma.com/news-events/press-releases/detail/1637/tonix-pharmaceuticals-to-report-second-quarter-2026 <![CDATA[Tonix Pharmaceuticals Announces Publication in the Peer-Reviewed Journal of Virology Assessing Virulence of the 2022 Outbreak Strain of Mpox in New Animal Models]]> https://ir.tonixpharma.com/news-events/press-releases/detail/1636/tonix-pharmaceuticals-announces-publication-in-the Wed, 15 Jul 26 09:05:00 -0400 https://ir.tonixpharma.com/news-events/press-releases/detail/1636/tonix-pharmaceuticals-announces-publication-in-the <![CDATA[Tonix Pharmaceuticals Announces Major Managed Medicare Payer Agreement for TONMYA®]]> https://ir.tonixpharma.com/news-events/press-releases/detail/1635/tonix-pharmaceuticals-announces-major-managed-medicare Mon, 13 Jul 26 07:00:00 -0400 https://ir.tonixpharma.com/news-events/press-releases/detail/1635/tonix-pharmaceuticals-announces-major-managed-medicare <![CDATA[Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 HORIZON Study of TNX-102 SL for the Treatment of Major Depressive Disorder (MDD)]]> https://ir.tonixpharma.com/news-events/press-releases/detail/1634/tonix-pharmaceuticals-announces-first-patient-enrolled-in Mon, 29 Jun 26 07:25:00 -0400 https://ir.tonixpharma.com/news-events/press-releases/detail/1634/tonix-pharmaceuticals-announces-first-patient-enrolled-in <![CDATA[Tonix Pharmaceuticals to Attend BTIG Infectious Disease Day 2026]]> https://ir.tonixpharma.com/news-events/press-releases/detail/1633/tonix-pharmaceuticals-to-attend-btig-infectious-disease-day Thu, 11 Jun 26 07:00:00 -0400 https://ir.tonixpharma.com/news-events/press-releases/detail/1633/tonix-pharmaceuticals-to-attend-btig-infectious-disease-day <![CDATA[Tonix Pharmaceuticals Secures Second Commercial Payer Agreement for TONMYA®, Expanding Total Commercial Coverage to ~52 Million U.S. Lives]]> https://ir.tonixpharma.com/news-events/press-releases/detail/1632/tonix-pharmaceuticals-secures-second-commercial-payer Mon, 08 Jun 26 07:00:00 -0400 https://ir.tonixpharma.com/news-events/press-releases/detail/1632/tonix-pharmaceuticals-secures-second-commercial-payer <![CDATA[Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis of Opioid Use in Patients with Fibromyalgia at the 2026 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting]]> https://ir.tonixpharma.com/news-events/press-releases/detail/1631/tonix-pharmaceuticals-presented-retrospective-u-s Thu, 28 May 26 16:30:00 -0400 https://ir.tonixpharma.com/news-events/press-releases/detail/1631/tonix-pharmaceuticals-presented-retrospective-u-s <![CDATA[Tonix Pharmaceuticals Announces Publication of Phase 1 Clinical Data of TNX-1500, an Fc-Modified anti-CD40L (CD154) Monoclonal Antibody, in the Peer-Reviewed Journal of Clinical Immunology]]> https://ir.tonixpharma.com/news-events/press-releases/detail/1630/tonix-pharmaceuticals-announces-publication-of-phase-1 Wed, 27 May 26 07:00:00 -0400 https://ir.tonixpharma.com/news-events/press-releases/detail/1630/tonix-pharmaceuticals-announces-publication-of-phase-1 <![CDATA[Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis Characterizing Patients with Fibromyalgia at The Professional Society for Health Economics and Outcomes Research (ISPOR) 2026 Annual Meeting]]> https://ir.tonixpharma.com/news-events/press-releases/detail/1629/tonix-pharmaceuticals-presented-retrospective-u-s Tue, 26 May 26 07:00:00 -0400 https://ir.tonixpharma.com/news-events/press-releases/detail/1629/tonix-pharmaceuticals-presented-retrospective-u-s